Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect.
about
Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of ActionSelective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signalingProtective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cellsAshwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activityDifferential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidencesGolden berry-derived 4β-hydroxywithanolide E for selectively killing oral cancer cells by generating ROS, DNA damage, and apoptotic pathwaysWater extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of actionCombinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiationTargeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer CellsFunctional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. RootsNovel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and ExtractsWithaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolite.Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cellsStress chaperone mortalin regulates human melanogenesis.Study of phytochemical, anti-microbial, anti-oxidant, and anti-cancer properties of Allium wallichii.Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cellsAnti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosisWithaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expressionMerger of ayurveda and tissue culture-based functional genomics: inspirations from systems biologyThe clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.Evaluation and Comparison of the In Vitro Cytotoxic Activity of Withania somnifera Methanolic and Ethanolic Extracts against MDA-MB-231 and Vero Cell LinesMood disorders and complementary and alternative medicine: a literature review.Withania somnifera: From prevention to treatment of cancerAutophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterizationAssessment of Cholinergic Properties of Ashwagandha Leaf-Extract in the Amnesic Mouse BrainRole of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.Relevance of mortalin to cancer cell stemness and cancer therapy.Biotechnological interventions in Withania somnifera (L.) Dunal.AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic modelsWithaferin A and its potential role in glioblastoma (GBM).Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancerQualitative and quantitative variations in withanolides and expression of some pathway genes during different stages of morphogenesis in Withania somnifera Dunal.Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
P2860
Q26766956-6A96210A-12EA-4CD0-9843-C027E2364CE3Q28475888-334D687B-46EA-4A8A-9260-93020F21EB27Q28477928-4F6F585E-B1B4-4C29-8CD1-965248F8861FQ28480426-032F8602-B06E-4FD1-BA33-4D255BD1571EQ28483352-DD04E4EA-D8EA-432D-BB4F-012374BFFC12Q28488396-15E22CD7-147D-405A-B9B2-BE816507AF7DQ28534335-D0989A92-FE84-4342-9981-82BA8CA6E4C5Q28544672-B6C54537-0201-4487-A81D-7B049C7F8E4FQ28548067-3B0EABF3-D656-489D-B301-E32BB4B30728Q28550976-5AC73431-286C-4E46-A819-6ED725918B09Q28554871-87315594-AD39-47EE-B77F-566CB0C9C540Q33690570-4B587AA4-4A6D-4081-9AD8-87834FB54CC3Q33815938-D3C66033-8692-4F6D-A0E4-743645D96008Q33900793-8B4DD8A8-71DB-434E-9BCB-D2FDD66904F3Q34987033-8C53D116-E198-4AB4-ABF1-0E4A86745DE9Q35983240-3DEF34A6-3618-4CE4-9D6E-B7A67A4E4490Q36274590-EBBD9259-8675-4A33-A5AB-C290D2D4B7C7Q36328445-E2CAA054-C766-408C-98FF-C4813E58EA4DQ36379354-5C869AA2-B4F9-4762-8FED-63690AE5B10FQ36488146-4CE0FF78-B3A7-458F-A1D8-59C213553572Q36557794-F908D261-3E15-42D6-800F-68C41AE86CE5Q36668140-68A84C24-4CCD-4ECD-AC86-0D41294AD672Q36796428-79C56152-EDF4-4401-96B3-EA308E98922AQ36821883-9DF48847-FBF4-488E-8C64-75E43BB5BABCQ36863056-79FC4C5B-EDC5-4F38-9870-603A6057B94BQ36984280-39E98AE1-E8BC-4381-ADF9-83A924F89E76Q37045996-60FC0606-0C5A-41A3-A93C-ADFFC7ADB137Q37075399-A2EA24A7-3483-412A-A739-A88C4BBAB822Q37232056-FF5794E9-B59F-4811-8208-459FB50E7AF7Q37251119-ADC38D81-9C5E-4C80-A53A-182822B48464Q37384594-0DDE738F-5B5B-4832-9B42-965159D43684Q37469387-EB05F5D3-FBF4-464B-A763-CCF6FB9BB1D1Q37488585-4D3F086B-17D0-4DD7-ABA8-5B5ABC415B5CQ37625726-DA658304-231C-44F0-B670-589B9A172EB9Q38383213-E8818BCE-02FB-49BC-887E-49819B6064BCQ38813184-5BD1C44F-8C4D-4019-BF62-1FA58BBBF9AFQ39006090-4CC0E5C7-0A46-4375-8CF8-BFC29F9EC823Q40997589-E9A4A155-5A38-40BE-9F45-8EB0C6787326Q44708755-664E4D37-1C94-4167-BF1B-4F3450F09675Q46724123-B11704DB-ADC4-4952-8357-DD4148688C5D
P2860
Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Selective killing of cancer ce ...... ecular insights to its effect.
@ast
Selective killing of cancer ce ...... ecular insights to its effect.
@en
Selective killing of cancer ce ...... ecular insights to its effect.
@nl
type
label
Selective killing of cancer ce ...... ecular insights to its effect.
@ast
Selective killing of cancer ce ...... ecular insights to its effect.
@en
Selective killing of cancer ce ...... ecular insights to its effect.
@nl
prefLabel
Selective killing of cancer ce ...... ecular insights to its effect.
@ast
Selective killing of cancer ce ...... ecular insights to its effect.
@en
Selective killing of cancer ce ...... ecular insights to its effect.
@nl
P2093
P1476
Selective killing of cancer ce ...... ecular insights to its effect.
@en
P2093
Bhupal G Shrestha
Kamaljit Kaur
Nashi Widodo
Tetsuro Ishii
Yasuomi Takagi
P304
P356
10.1158/1078-0432.CCR-06-0948
P407
P577
2007-04-01T00:00:00Z